HMD Insider Trading

Insider Ownership Percentage: 24.22%
Insider Buying (Last 12 Months): A$1,433.34
Insider Selling (Last 12 Months): A$0.00

HeraMED Insider Trading History Chart

This chart shows the insider buying and selling history at HeraMED by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HeraMED Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for HMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

HeraMED Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/28/2024David HintonInsiderBuy71,667A$0.02A$1,433.34
3/23/2023Ronald (Ron) WeinbergerInsiderBuy215,000A$0.11A$24,510.00
12/7/2021David GrobermanInsiderBuy463,752A$9.28A$4,303,618.56
See Full Table

SEC Filings (Institutional Ownership Changes) for HeraMED (ASX:HMD)

6.40% of HeraMED stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

HeraMED logo
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Netanya, Israel.
Read More on HeraMED

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

98,572 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of HeraMED?

HeraMED's top insider investors include:
  1. David Hinton (Insider)
  2. Ronald (Ron) Weinberger (Insider)
Learn More about top insider investors at HeraMED.